Amundi Asset Management US’s Dr. Reddy's Laboratories RDY Stock Holding History

Amundi Asset Management US’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$4.03M	Buy	327,785 +223,500	+214%	+$2.87M	﹤0.01%	1065
2020 Q4	$1.49M	Sell	104,285 -172,450	-62%	-$2.32M	﹤0.01%	1164
2020 Q3	$3.85M	Buy	276,735 +95,075	+52%	+$1.13M	﹤0.01%	967
2020 Q2	$1.93M	Buy	181,660 +77,375	+74%	+$787K	﹤0.01%	1084
2020 Q1	$842K	Sell	104,285 -2,900	-3%	-$24.2K	﹤0.01%	1120
2019 Q4	$870K	Sell	107,185 -163,680	-60%	-$1.29M	﹤0.01%	1263
2019 Q3	$2.05M	Buy	270,865 +16,680	+7%	+$124K	﹤0.01%	1092
2019 Q2	$1.91M	Sell	254,185 -12,000	-5%	-$94.3K	﹤0.01%	1150
2019 Q1	$2.16M	Buy	266,185 +110,000	+70%	+$836K	﹤0.01%	1076
2018 Q4	$1.18K	Buy	156,185 +86,000	+123%	+$605K	﹤0.01%	1131
2018 Q3	$486K	Buy	70,185 +15,500	+28%	+$104K	﹤0.01%	1367
2018 Q2	$352K	Hold	54,685	–	–	﹤0.01%	1382
2018 Q1	$357K	Sell	54,685 -27,980	-34%	-$196K	﹤0.01%	1308
2017 Q4	$621K	Buy	+82,665	New	+$595K	﹤0.01%	1262

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Amundi Asset Management US's RDY Position: Q1 2021 in Review

Amundi Asset Management US increased its Dr. Reddy's Laboratories (RDY) stake by 214% in Q1 2021, buying an estimated $2.87M and bringing the position to 327,785 shares worth $4.03M. The position accounts for ﹤0.01% of the portfolio, ranked #1065.

Amundi Asset Management US first reported a position in RDY in Q4 2017 and has held it in 14 quarters since. 161 funds tracked by Wall St. Rank hold RDY as of Q1 2021.

Amundi Asset Management US held 327,785 shares of Dr. Reddy's Laboratories worth $4.03M as of Q1 2021.
Amundi Asset Management US bought 223,500 Dr. Reddy's Laboratories shares in Q1 2021, an estimated $2.87M.
Dr. Reddy's Laboratories made up ﹤0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #1065 holding.
Amundi Asset Management US first reported a position in Dr. Reddy's Laboratories in Q4 2017 and has held it in 14 quarters since.
161 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.